Enhancer of zeste homolog 2 (EZH2), a core component of polycomb repressive component
2 is overexpressed in a variety of cancers and recognized as a therapeutic target molecule …

Enhancer of zeste homolog 2 (EZH2) is aberrantly expressed or mutated in multiple types of
cancer cells and plays an oncogenic role in tumorigenesis and development in most …

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death. The
accumulation of genetic and epigenetic changes is closely related to the occurrence and …

Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive
complex 2 (PRC2), which regulates downstream gene expression by trimethylation of lysine …

Abstract Background Enhancer of Zeste homologue 2 (EZH2) is a polycomb group gene and
an epigenetic regulator that inhibits transcription, a modification associated with gene …

Abstract Background & Aims: The incidence and mortality of hepatocellular carcinoma
(HCC) are increasing. It is urgent to develop more effective HCC biomarkers for diagnosis …

Enhancer of zeste homolog (EZH2) is a key epigenetic regulator of gene expression and is
frequently overexpressed in various cancer types, suggesting a role in oncogenesis. The …

Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein
family, has been demonstrated to be overexpressed in various types of human cancer …

The enhancer of zeste homolog 2 (EZH2) plays a critical role in different components of anti-
tumor immunity. However, the specific role of EZH2 in modulating MHC Class I antigen …

Objective To screen the possible potential signaling pathways related to enhancer of zeste
homolog 2 (EZH2) based on ceRNA mechanism, and to analyze the correlation between …